Brain volume loss

November 6, 2018November 6, 2018

Diabetes, Hypertension, Smoking Linked with Brain Shrinkage in MS Patients

News

Diabetes, hypertension, and active smoking correlate with more brain shrinkage in multiple sclerosis (MS) patients, a new study shows. The study, “Assessing the burden of vascular risk factors on ... Read more

July 11, 2018July 18, 2018

Rate of Brain Volume Loss Not Adequate as Marker of Treatment Effectiveness in MS Patients, Study Reports

News

Brain volume loss takes place at a faster rate in the first five years of multiple sclerosis than later in disease course, researchers report in a study that calls for ... Read more

February 8, 2018March 27, 2018

#ACTRIMS2018 – Ozanimod Reduces MS Relapses and Brain Deterioration, Phase 3 Trial Shows

News

Celgene’s Ozanimod reduces relapsing multiple sclerosis patients’ relapses, brain lesions, and brain volume loss, a Phase 3 clinical trial shows. The company presented the results of the SUNBEAM trial at the ACTRIMS Forum ... Read more

February 23, 2017May 1, 2018

#ACTRIMS2017 – Lemtrada Maintains Durable Positive Effects in MS Without Additional Treatment

Lemtrada, News

Two Phase 3 clinical trials investigating the long-term effects of Lemtrada (alemtuzumab) in multiple sclerosis (MS) patients showed the drug maintained improved outcomes, even in the absence of further ... Read more

February 14, 2017February 20, 2017

Cladribine Tablets Reduce Brain Atrophy in MS Patients, Merck Study Finds

News

EMD Soreno has recently published Phase 3 clinical data showing that Cladribine tablets reduced the annualized rate of brain volume loss (BVL, brain atrophy) compared to placebo in patients with relapsing-remitting multiple ... Read more

September 21, 2016September 21, 2016

#ECTRIMS2016 – MS Patients on Oral Gilenya Stick Longer with Treatment in Phase 4 Study

News

A recent study showed that after one year, the majority of multiple sclerosis (MS) patients taking oral Gilenya (fingolimod) therapy stuck with their treatment, while a large proportion of ... Read more

May 9, 2016May 9, 2016

#CMSC16 – High Glutamate Levels in Brain Seen to Drive MS Progression

News

Patients with multiple sclerosis (MS) have increased levels of the neurotransmitter glutamate in their brains, lowering the levels of N-acetylaspartate (NAA) — a process that likely leads to the loss ... Read more

April 20, 2016April 20, 2016

Sanofi Genzyme Presenting New Data on Lemtrada’s Beneficial Effects, Drawn from RRMS Extension Study, at AAN 2016

News

Sanofi Genzyme is presenting promising data regarding brain volume and retinal nerve fibers in multiple sclerosis (MS) patients — drawn from an ongoing extension study into the disease-modifying drug alemtuzumab (Lemtrada) — ... Read more

February 10, 2016February 10, 2016

MS Study Finds Lipid Antibodies Reflect Changes in Brain Volume and Lesions

News

Brigham and Women’s Hospital researchers reported that antibodies directed at lipids are associated with magnetic resonance imaging (MRI) measures of brain degeneration in patients with multiple sclerosis (MS), and may potentially ... Read more

October 9, 2015October 9, 2015

Biometrica MS Launched at ECTRIMS 2015 to Support Routine Multiple Sclerosis Care

News

Biometrica MS®, a technology that provides an easy to use service for neurologists to quantify lesion load as well as brain volume measures in clinical practice, is a web-based ... Read more

Pin It on Pinterest